top of page
MBT-2 - Syngeneic Model
Rincon Bio performs MBT-2 syngeneic models to test efficacy of immunotherapies. Please see below for additional information or to request a quote.
Bladder
Organism: Mus musculus, mouse Breed/subspecies: C3H/He / Tissue: Bladder / Disease: Transitional Cell Carcinoma
Notes
Mouse Bladder Tumor line-2
in vivo
Used as a syngeneic model. Implanted tumor cells create a model in which to test the efficacy of novel immunotherapies
Request Quote
Receive a quote within one business day for a MBT-2 syngeneic study
Rincon Bio Growth Curve

Cell Line: MBT2
Mouse Strain: CH3
Gender: female
Positive Control: Anti-PD1
Concentration: 2.5 & 5 mg/kg
Tumor target size for stratification: 50 mm^3
From implant to stratification: 10 days
Cells Implanted per Animal: 5x10^5
WHY WORK WITH
RINCON BIO?
DOMESTIC QUALITY at COMPETITIVE PRICES
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
bottom of page